View |
|
BRP-083
|
Rituximab
|
Truxima
|
500mg
|
Concentrate for Solution for Infusion
(IV)
|
-
|
Celltrion Incorporated (Plant 2)
|
Korea
|
Renewal
|
06 July 2023
|
13 June 2028
|
View |
|
BRP-084
|
Epoetin Beta
|
Recormon
|
5000 IU/ 0.3 mL
|
Solution For Injection
|
Hematopoietic Growth Factor
|
Roche Diagnostic GmBH
|
Germany
|
Automatic Renewal
|
14 September 2021
|
05 November 2026
|
View |
|
BRP-085
|
Heparin Sodium
|
Bruhep
|
1,000 IU/Ml
|
Solution for Injection (IV/SC)
|
Antithrombotic agents
|
Brawn Laboratories Limited
|
India
|
Automatic Renewal
|
17 January 2023
|
11 October 2028
|
View |
|
BRP-085-01
|
Heparin Sodium
|
Cenprahep
|
1000 IU/mL
|
Solution For Injection (IV/SC)
|
Antithrombotic agents
|
Brawn Laboratories Limited
|
India
|
Automatic Renewal
|
07 March 2023
|
11 October 2028
|
View |
|
BRP-086
|
Human Normal Immunoglobulin
|
Bioven Mono
|
50mg/Ml (5% w/v)
|
Solution For Injection (I.V.)
|
Immunoglobulin
|
Biofarma Plasma Limited Liability Company
|
Ukraine
|
Renewal
|
05 December 2023
|
29 May 2029
|
View |
|
BRP-090
|
Equine Anti-Rabies Immunoglobulin
|
Vinrab
|
200 IU/mL (1000 IU/5mL)
|
Solution For Injection I.M
|
Immunoglobulins
|
Vins Bioproducts, Ltd.
|
India
|
Renewal
|
21 March 2024
|
16 March 2029
|
View |
|
BRP-091
|
Epoetin Alfa
|
Binocrit
|
40,000 IU/ mL
|
Solution For Injection (IV/SC)
|
-
|
IDT Biologika GmbH
|
Germany
|
-
|
02 April 2020
|
02 April 2025
|
View |
|
BRP-092
|
Epoetin Alfa
|
Binocrit
|
4,000 IU/ 0.4 Ml
|
Solution For Injection (IV/SC)
|
-
|
IDT Biologika GmbH
|
Germany
|
-
|
02 April 2020
|
02 April 2025
|
View |
|
DR-721
|
Balanced Multiple Maintenance Solution With 5% Dextrose (See formulation on reverse side)
|
Multisol-M In D5 Water
|
Each 100 mL contains 5 g Dextrose Monohydrate; 234 mg Sodium Chloride; 128 mg Potassium Acetate; 21 mg Magnesium Acetate & 30 mg Sodium Metabisulfite
|
Solution For Iv Infusion
|
Electrolyte Replenisher
|
Euro-Med Laboratories Phil., Inc
|
Philippines
|
Automatic Renewal
|
03 September 2020
|
16 October 2025
|
View |
|
DR-10073
|
Clobetasol Propionate
|
Dermovate
|
500 mcg/g
|
Ointment
|
Corticosteroid
|
GlaxoSmithKline Pharmaceuticals S.A.
|
Poland
|
Initial
|
15 June 2023
|
15 June 2028
|
View |
|
DR-10074
|
Clobetasol Propionate
|
Dermovate
|
500 mcg/g
|
Cream
|
-
|
GlaxoSmithKline Pharmaceuticals S.A.
|
Poland
|
Initial
|
18 January 2023
|
18 January 2028
|
View |
DR-10256_PI_01.pdf
|
DR-10256
|
Prednisolone (as acetate)
|
Pred Forte
|
|
Sterile Suspension (Opthalmic Drops)
|
Anti-Inflammatory (Steroidal)
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Renewal
|
13 January 2022
|
03 March 2027
|
View |
|
DR-1110
|
Furosemide
|
Lasix
|
40 mg
|
Tablet
|
Diuretic
|
Handok Inc.
|
Korea
|
Automatic Renewal
|
07 March 2023
|
15 April 2028
|
View |
|
DR-1111
|
Furosemide (as sodium)
|
Lasix
|
10 mg/mL (20 mg/2 mL)
|
Solution For Injection (IV/IM)
|
-
|
Delpharm Dijon
|
France
|
-
|
03 August 2020
|
01 July 2025
|
View |
|
DR-1168
|
Sodium Fusidate
|
FUCIDIN
|
250 mg
|
Film-Coated Tablet
|
Antibacterial
|
Laboratories LEO S.A.
|
France
|
Renewal
|
25 July 2024
|
23 October 2029
|
View |
|
DR-1170
|
Sodium Fusidate
|
Fucidin
|
20mg/ g
|
Ointment
|
Antibacterial
|
Leo Laboratories Ltd.
|
Ireland
|
Renewal
|
21 October 2024
|
27 March 2030
|
View |
|
DR-1437
|
Fluocinolone Acetonide + Polymyxin B Sulfate + Neomycin Sulfate
|
Synalar
|
250 mcg/ 10,000 I.U./ 5 mg per mL
|
Otic Solution
|
Corticosteroid/Antibiotic
|
Interphil Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 September 2020
|
18 October 2025
|
View |
|
DR-153
|
Paracetamol
|
Biogesic
|
500 mg
|
Tablet
|
Analgesic/Antipyretic
|
United Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
05 January 2023
|
02 April 2028
|
View |
|
DR-1773
|
Erythromycin (as estolate)
|
ILOSONE
|
100 mg/mL
|
Suspension (Oral Drops)
|
Antibacterials (Macrolides)
|
Interphil Laboratories
|
Philippines
|
Renewal
|
14 March 2022
|
22 April 2027
|
View |
|
DR-1779
|
Erythromycin (as estolate)
|
ILOSONE
|
125 mg/ 5mL
|
Suspension
|
Antibacterials (Macrolides)
|
Interphil Laboratories
|
Philippines
|
Renewal
|
21 March 2022
|
13 May 2027
|